Well done, MMPJoe. I know nothing about Donohoe Advisory and I doubt if 99% of investors have heard of them. However, the action seems absolutely right on at this point in time. You and the management team can't be expected to know everything that pertains to the re-making of Generex, although our expectations are high. The fee Generex pays will be worth it, and then some, if Donohoe is successful. Besides it frees up management to dedicate themselves to the other initiatives that are in play.